Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Astrocytoma
New astrocytoma research has been reported by W.Y. Yue et al
May 12th, 2009
"Astrocytoma may progress rapidly or remain stable for many years. To clarify whether molecular characteristics Could be prognostic factors, several cell cyclin-associated molecular alterations in the diffuse astrocytoma have been investigated," researchers in Guangzhou, People's Republic of China report. "Thirty-three patients in whom WHO Grade II astrocytonia. had been initially diagnosed were assigned to 1 of 3 groups. Group 1 consisted of 10 patients with malignant progression; the tumor had recurred within 5 years and histological analysis had confirmed that the tumor progressed to Grade III or IV. Group 2 consisted of 10 patients in whom there was no malignant...
Source: Cancer Weekly (2009-05-12)
|
